The effect of alpha ointment in treatment of burned patients

Phase 3

Conditions: Burning.
Contact with hot drinks, food, fats and cooking oils
Contact with hot tap-water
Contact with other hot fluids
X10
X11

Registration Number: IRCT2015110624905N1

Lead Sponsor: Zanjan University of Medical Science

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 40

Inclusion Criteria

Second degree heat burned patients; burning surface area between 10% and 20%
Exclusion criteria:Iisolated head and neck burning; burning of genitalia; pregnant women; first and third and fourth degree burning; unstable patients; burning surface area above 20% or under 10%; patients with history of neurocycotic diseases who are under treatment; addiction to opioids; smokers; patients with history of cardiac, renal or hepatic diseases; diabetic patients; malnutrished patients; patients under treatment of corticosteroids or other immune suppressive treatments; inhalative burnings; sulfunamid toxicity; old burnings

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of ulcer healing. Timepoint: Seventh, 14th, 30th day. Method of measurement: Evaluation of patient in the admission time and evaluation of ulcers in 7th and 14th day of admission and out patient in day 30th. In every visit photography of ulcers was done.;The rate of scar. Timepoint: Thirtieth day. Method of measurement: Two other colleagues who were not aware of our protocol, visited patients in 30th day and scored rate of scar in 4 qualitative scale item like excellent, good, intermediate, poor. And the remaining scar was reported in percentage.;The rate of positive culture. Timepoint: First, 7th, 14th day. Method of measurement: The cuture of wound swap in the first, 7th and 14th day of admission.

Secondary Outcome Measures

Name	Time	Method
The rate of patients' pain. Timepoint: Daily. Method of measurement: VAS (visual analogue scale) in first 14 day.;Dose of recieved analgesia. Timepoint: Daily. Method of measurement: Evaluation of pethidine consumption in firs 14 day.;Days of admission. Timepoint: Daily. Method of measurement: Questionnarie.